Extended Spectrum Beta Lactamase Escherichia Coli in Bagmati River, Kathmandu Valley.

Q3 Medicine
Bindu Ghimire, Muna Kumari Pokherel, Megha Raj Banjara, Komal Raj Rijal, Prakash Ghimire
{"title":"Extended Spectrum Beta Lactamase Escherichia Coli in Bagmati River, Kathmandu Valley.","authors":"Bindu Ghimire, Muna Kumari Pokherel, Megha Raj Banjara, Komal Raj Rijal, Prakash Ghimire","doi":"10.33314/jnhrc.v21i4.5031","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance organisms in the peripheral communities of an environment can be predicted by the presence of extended-spectrum beta-lactamase Escherichia coli in that environment. The close connectivity between humans and water sources can facilitate the entry of antimicrobial resistant organisms into the human ecosystem. The aim of this study was to assess beta lactamase producing Escherichia coli from Bagmati river within Kathmandu valley.</p><p><strong>Methods: </strong>In the year 2020, a cross-sectional study was conducted on water samples collected from 66 locations along the Bagmati River. Coliforms were isolated by five tubes dilution method and identified by cultural and biochemical tests. Further Escherichia coli was isolated in eosin methylene blue agar at 44.5 ⁰C. Antibiotic susceptibility test was performed by Kirby Bauer disk diffusion methods. Beta lactamase gene types were detected by using conventional multiplex polymerase chain reaction.</p><p><strong>Results: </strong>A total of 615 bacterial isolates were identified among which 39 % (n=241) were Escherichia coli. Extended spectrum beta lactamase producing Escherichia coli was confirmed in 16.6 % (40/241) of total Escherichia coli isolates. Among 66 sites this isolate was detected in 26 (40 %) sampling sites excluding upstream regions. All the Escherichia coli isolates were multidrug resistance showing higher percentage (>99 %) of resistant for penicillin, tetracycline and erythromycin antibiotics. There were significant differences in resistance rate for cefotaxime and ceftazidime by extended spectrum beta lactamase producing and non-producing Escherichia coli (p<0.05).</p><p><strong>Conclusions: </strong>Presence of multidrug resistance extended spectrum beta lactamase producing Escherichia coli in river streams suggests the chances of circulating within river system and hence transmitting in human community.</p><p><strong>Key words: </strong>Bagmati river; drug resistance; escherichia coli; human.</p>","PeriodicalId":16380,"journal":{"name":"Journal of Nepal Health Research Council","volume":"21 4","pages":"672-679"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nepal Health Research Council","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33314/jnhrc.v21i4.5031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Antimicrobial resistance organisms in the peripheral communities of an environment can be predicted by the presence of extended-spectrum beta-lactamase Escherichia coli in that environment. The close connectivity between humans and water sources can facilitate the entry of antimicrobial resistant organisms into the human ecosystem. The aim of this study was to assess beta lactamase producing Escherichia coli from Bagmati river within Kathmandu valley.

Methods: In the year 2020, a cross-sectional study was conducted on water samples collected from 66 locations along the Bagmati River. Coliforms were isolated by five tubes dilution method and identified by cultural and biochemical tests. Further Escherichia coli was isolated in eosin methylene blue agar at 44.5 ⁰C. Antibiotic susceptibility test was performed by Kirby Bauer disk diffusion methods. Beta lactamase gene types were detected by using conventional multiplex polymerase chain reaction.

Results: A total of 615 bacterial isolates were identified among which 39 % (n=241) were Escherichia coli. Extended spectrum beta lactamase producing Escherichia coli was confirmed in 16.6 % (40/241) of total Escherichia coli isolates. Among 66 sites this isolate was detected in 26 (40 %) sampling sites excluding upstream regions. All the Escherichia coli isolates were multidrug resistance showing higher percentage (>99 %) of resistant for penicillin, tetracycline and erythromycin antibiotics. There were significant differences in resistance rate for cefotaxime and ceftazidime by extended spectrum beta lactamase producing and non-producing Escherichia coli (p<0.05).

Conclusions: Presence of multidrug resistance extended spectrum beta lactamase producing Escherichia coli in river streams suggests the chances of circulating within river system and hence transmitting in human community.

Key words: Bagmati river; drug resistance; escherichia coli; human.

加德满都谷地巴格马蒂河中的广谱β-内酰胺酶大肠埃希氏菌。
背景:通过环境中存在的广谱β-内酰胺酶大肠埃希氏菌,可以预测环境外围群落中的抗菌药耐药性生物。人类与水源之间的密切联系会促使耐抗菌生物进入人类生态系统。本研究旨在评估加德满都谷地巴格马蒂河中产β内酰胺酶的大肠埃希氏菌:2020 年,对巴格马蒂河沿岸 66 个地点采集的水样进行了横断面研究。采用五管稀释法分离大肠菌群,并通过文化和生化测试进行鉴定。此外,还在 44.5 ⁰C 的曙红亚甲蓝琼脂中分离出大肠埃希氏菌。抗生素敏感性测试采用柯比鲍尔盘扩散法进行。采用传统的多重聚合酶链反应检测β-内酰胺酶基因类型:结果:共鉴定出 615 株细菌分离物,其中大肠埃希菌占 39%(n=241)。在所有大肠埃希菌分离物中,16.6%(40/241)被证实为产广谱β内酰胺酶大肠埃希菌。在 66 个采样点中,除上游地区外,有 26 个(40%)采样点检测到了这种分离菌。所有大肠埃希菌分离物均对多种药物产生耐药性,对青霉素、四环素和红霉素抗生素的耐药性比例较高(>99%)。产生和不产生广谱β-内酰胺酶的大肠埃希菌对头孢他啶和头孢唑肟的耐药率存在明显差异(结论:产生广谱β-内酰胺酶的大肠埃希菌和不产生广谱β-内酰胺酶的大肠埃希菌对头孢他啶和头孢唑肟的耐药率存在明显差异:河水中存在产生多药耐药性的广谱β-内酰胺酶大肠埃希菌,这表明它们有可能在河流系统中循环,从而在人类社区中传播:巴格马蒂河;耐药性;大肠埃希氏菌;人类。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
81
审稿时长
15 weeks
期刊介绍: The journal publishes articles related to researches done in the field of biomedical sciences related to all the discipline of the medical sciences, medical education, public health, health care management, including ethical and social issues pertaining to health. The journal gives preference to clinically oriented studies over experimental and animal studies. The Journal would publish peer-reviewed original research papers, case reports, systematic reviews and meta-analysis. Editorial, Guest Editorial, Viewpoint and letter to the editor are solicited by the editorial board. Frequently Asked Questions (FAQ) regarding manuscript submission and processing at JNHRC.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信